Jaeseong Oh

ORCID: 0000-0001-6275-8587
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Treatment and Management
  • Pharmacogenetics and Drug Metabolism
  • Pharmacological Effects and Toxicity Studies
  • Drug Transport and Resistance Mechanisms
  • Metabolism, Diabetes, and Cancer
  • Antibiotics Pharmacokinetics and Efficacy
  • Pancreatic function and diabetes
  • Statistical Methods in Clinical Trials
  • Anesthesia and Sedative Agents
  • Health Systems, Economic Evaluations, Quality of Life
  • Epilepsy research and treatment
  • Heart Failure Treatment and Management
  • Potassium and Related Disorders
  • Gastroesophageal reflux and treatments
  • Advanced Combinatorial Mathematics
  • Helicobacter pylori-related gastroenterology studies
  • Analytical Methods in Pharmaceuticals
  • Tuberculosis Research and Epidemiology
  • Pharmacology and Obesity Treatment
  • Pneumonia and Respiratory Infections
  • Pharmaceutical Economics and Policy
  • Blood disorders and treatments
  • Bacterial Infections and Vaccines
  • Anesthesia and Neurotoxicity Research
  • Retinal Development and Disorders

Seoul National University Hospital
2016-2025

Jeju National University
2023-2025

Jeju National University Hospital
2024-2025

New Generation University College
2018-2024

Seoul National University
2018-2024

National University College
2018-2024

Weatherford College
2024

Ewha Womans University
2023

Yonsei University
2023

Severance Hospital
2023

Abstract Despite substantial advances in disease genetics, studies to date have largely focused on individuals of European descent. This limits further discoveries novel functional genetic variants other ethnic groups. To alleviate the paucity East Asian population genome resources, we established Korean Variant Archive 2 (KOVA 2), which is composed 1896 whole-genome sequences and 3409 whole-exome from healthy ethnicity. largest database date, surpassing 1909 deposited gnomAD. The KOVA...

10.1038/s12276-022-00871-4 article EN cc-by Experimental & Molecular Medicine 2022-11-02

Digital therapeutics (DTx) are software-based therapeutic interventions based on clinical evidence. Randomized trials (RCTs) often the source of evidence, similar to conventional drugs or medical devices. However, novel approaches such as use real-world data digital biomarkers also utilized. This article aimed review how DTx products have been clinically evaluated.DTx approved by US Food and Drug Administration 2020 were reviewed with sufficient published information selected. Pivotal...

10.4258/hir.2022.28.3.188 article EN cc-by-nc Healthcare Informatics Research 2022-07-31

Hermansky-Pudlak syndrome (HPS) is a rare, often fatal, autosomal recessive disorder in which albinism, bleeding and lysosomal storage are associated with defects of diverse cytoplasmic organelles, including melanosomes, platelet dense granules lysosomes. Similar multi-organellar occur the Chediak-Higashi (CHS), as well large number different mouse mutants. The HPS gene located 10q23, two genetically distinct loci, pale ear (ep) ruby-eye (ru), both mutant phenotypes similar to human HPS, map...

10.1093/hmg/6.5.793 article EN Human Molecular Genetics 1997-05-01

A novel potassium-competitive acid blocker, DWP14012, is in clinical development as a potential alternative to proton pump inhibitors for the treatment of acid-related diseases.To evaluate safety, tolerability, pharmacodynamics and pharmacokinetics DWP14012 humans.A randomised, double-blind, double-dummy, placebo- active-controlled, single- multiple-ascending dose (SAD MAD, respectively) study was conducted healthy male subjects without Helicobacter pylori infection. Subjects randomly...

10.1111/apt.14818 article EN Alimentary Pharmacology & Therapeutics 2018-06-04

Zastaprazan (JP-1366) is a novel potassium-competitive acid blocker with favourable preclinical safety and efficacy profile being developed for the treatment of acid-related diseases.To investigate safety, tolerability, pharmacodynamics pharmacokinetics zastaprazan.A randomised, open-label, placebo- active-controlled, single multiple ascending dose clinical trial was conducted in healthy Korean male subjects. Intragatric pH serum gastrin were measured to assess pharmacodynamics, while serial...

10.1111/apt.17406 article EN Alimentary Pharmacology & Therapeutics 2023-02-02

Chemotherapy-induced alopecia (CIA) is a side effect of the anticancer drug 5-fluorouracil (5-FU). However, mechanism action in hair follicle cells unclear. This study investigated 5-FU on cycle and growth vitro vivo. Intraperitoneal injection into C57BL/6 mice delayed anagen initiation, resulting small follicles. inhibited angiogenesis by reducing cluster differentiation 31+ cells, vascular endothelial factor, fetal liver kinase-1 expression mouse skin tissue rat vibrissa dermal papilla...

10.1016/j.cbi.2025.111416 article EN cc-by-nc-nd Chemico-Biological Interactions 2025-02-01

Abstract Background and aim Severe fever with thrombocytopenia syndrome (SFTS) is a fatal tick-borne infectious disease lacking effective treatments or vaccines. Early identification of prognostic factors essential for optimizing clinical management. This study investigated the predictors mortality in SFTS patients. Methods We conducted retrospective multicenter cohort 413 patients hospitalized South Korea from 2013 to 2024. Clinical laboratory data were comprehensively analyzed evaluate...

10.1186/s12879-025-10661-8 article EN cc-by BMC Infectious Diseases 2025-02-25

Abstract Severe fever with thrombocytopenia syndrome (SFTS) is a fatal tick-borne infectious disease that lacks effective treatments. Dynamic analysis reflects changes in the SFTS patient’s condition needed. This study aimed to evaluate time-dependent predictive performance of key biomarkers using Cox regression model. A retrospective multicenter cohort was conducted on 440 patients hospitalized South Korea between 2013 and 2024. Time-dependent receiver operating characteristic (ROC)...

10.1038/s41598-025-94416-0 article EN cc-by Scientific Reports 2025-03-18

Abstract Background Post-transplantation cyclophosphamide (PTCy) has paved the way for increased use of alternative donors, including haploidentical familial with acceptable engraftment and graft-versus-host disease (GVHD) rates. However, pharmacokinetic studies PTCy in pediatric population following myeloablative conditioning regimens are scarce. Methods We conducted a prospective comprehensive analysis pre- post-transplantation levels patients undergoing hematopoietic stem cell...

10.1186/s40364-025-00749-3 article EN cc-by Biomarker Research 2025-03-24

The intraocular route of drug administration enables the delivery high concentrations therapeutic drugs, while minimizing their systemic absorption. Several drugs are administered into anterior chamber or vitreous, and injection has been effective in curing various diseases. Rabbit eyes have widely used for ophthalmic research, as animal is easy to handle economical compared other mammals, size a rabbit eye similar that human eye. Using 30 G needle, can be injected intracameral intravitreal...

10.3791/53878 article EN Journal of Visualized Experiments 2016-07-23

Summary Background Potassium‐competitive acid blockers (P‐CABs) are emerging as novel treatments for acid‐related disorders including gastroesophageal reflux disease. Tegoprazan and revaprazan approved P‐CABs in South Korea, but the pharmacodynamics safety/tolerability of two drugs have never been compared. Aims To evaluate tegoprazan after single multiple oral doses Methods A randomised, open‐label, active‐controlled study was conducted Helicobacter pylori ‐negative healthy Korean male...

10.1111/apt.16121 article EN Alimentary Pharmacology & Therapeutics 2020-11-01

We hypothesized that the pharmacodynamic (PD) characteristics of metformin would change with inhibition multidrug and toxin extrusion (MATE) transporter, which mediates renal elimination metformin. Twenty healthy male subjects received two doses (750/500 mg) metformin, without 50 mg pyrimethamine (a potent MATE inhibitor), 1 week washout in between each dose. The PD were assessed using oral glucose tolerance tests (OGTTs) before after Metformin concentrations plasma urine determined liquid...

10.1111/dom.12577 article EN Diabetes Obesity and Metabolism 2015-09-18

DWP16001 is a novel sodium-glucose cotransporter-2 inhibitor under development for the treatment of type 2 diabetes mellitus. This study was conducted to evaluate pharmacokinetics, pharmacodynamics and safety after single multiple doses in healthy subjects.A randomized, double-blind, placebo- active-controlled, single- multiple-dose conducted. Twelve subjects each dose group received (0.2, 0.5, 1.0, 2.0 or 5.0 mg) (0.1, 0.3, 1.0 mg once daily 15 consecutive days) DWP16001, dapagliflozin 10...

10.1111/bcp.15348 article EN British Journal of Clinical Pharmacology 2022-04-08

Decreased oral clopidogrel absorption caused by induction of intestinal permeability glycoprotein (P-gp) expression after aspirin administration was observed in rats. This study evaluated the effect coadministration on pharmacokinetics/pharmacodynamics humans. A single 75-mg dose orally administered before and 2 4 weeks once-daily 100-mg 18 healthy volunteers who were recruited based CYP2C19 PON1 genotypes. Plasma concentrations its active metabolite, H4, relative platelet inhibition (RPI)...

10.1038/clpt.2014.49 article EN Clinical Pharmacology & Therapeutics 2014-02-24

Background The aim of this study was to explore the pharmacokinetic-pharmacodynamic (PK-PD) relationship metformin on glucose levels after administration 250 mg and 1000 in healthy volunteers. Methods A total 20 male volunteers were randomized receive two doses either a low dose (375 followed by mg) or high (1000 at 12-h intervals. pharmacodynamics assessed using oral tolerance tests before administration. PK parameters second evaluated through noncompartmental analyses. Four single...

10.1371/journal.pone.0191258 article EN cc-by PLoS ONE 2018-01-17

Abstract Sildenafil is widely used off-label in pediatric patients with pulmonary arterial hypertension (PAH). This study was conducted to characterize the pharmacokinetics (PK) of sildenafil term and preterm neonates PAH, by developing a population PK model, suggest appropriate doses achieve clinically effective concentrations. A modelling analysis performed using its metabolite N-desmethyl (DMS) concentration data from 19 whose gestational ages ranged 24–41 weeks. They received orally at...

10.1038/s41598-022-11038-6 article EN cc-by Scientific Reports 2022-05-05

Abstract Bersiporocin, a novel first‐in‐class prolyl‐tRNA synthetase (PRS) inhibitor currently under clinical development, was shown to exert an antifibrotic effect through the downregulation of collagen synthesis in various pulmonary fibrosis models. The aim this first‐in‐human, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐dose, dose‐escalation study evaluate safety, tolerability, pharmacokinetic (PK) pharmacodynamic (PD) characteristics bersiporocin healthy adults. A...

10.1111/cts.13518 article EN cc-by-nc-nd Clinical and Translational Science 2023-04-24

Anti-tuberculosis (AT) medications, including isoniazid (INH), can cause drug-induced liver injury (DILI), but the underlying mechanism remains unclear. In this study, we aimed to identify genetic factors that may increase susceptibility of individuals AT-DILI and examine interactions lead (INH)-induced hepatotoxicity. We performed a targeted sequencing analysis 380 pharmacogenes in discovery cohort 112 patients (35 77 controls) receiving AT treatment for active tuberculosis....

10.1038/s12276-024-01172-8 article EN cc-by Experimental & Molecular Medicine 2024-03-01

The intraocular route of drug administration enables the delivery high concentrations therapeutic drugs, while minimizing their systemic absorption.Several drugs are administered into anterior chamber or vitreous, and injection has been effective in curing various diseases.Rabbit eyes have widely used for ophthalmic research, as animal is easy to handle economical compared other mammals, size a rabbit eye similar that human eye.Using 30 G needle, can be injected intracameral intravitreal...

10.3791/53878-v article EN Journal of Visualized Experiments 2016-07-23

Background: Colistin is increasingly used as the last therapeutic option for treatment of multidrug-resistant, Gram-negative bacterial infections. To ensure safe and efficacious use colistin, drug monitoring (TDM) needed due to its narrow window. This study aimed evaluate pharmacokinetic (PK) characteristics colistin guide TDM in colistin-treated patients Korea. Methods: In a prospective study, we analyzed PK 15 who intravenously received methanesulfonate twice per day. doses were adjusted...

10.1097/ftd.0000000000000572 article EN Therapeutic Drug Monitoring 2018-10-06

Human carboxylesterase 1 (CES1) is a serine esterase that hydrolyses various exogenous and endogenous compounds including oseltamivir, prodrug used to treat influenza. A novel CES1 c.662A>G single nucleotide polymorphism (SNP) was predicted decrease enzymatic activity in an silico analysis. This study evaluated the effect of SNP on pharmacokinetics (PK) oseltamivir humans.A oral dose at 75 mg administered 20 healthy subjects, 8 heterozygous carriers (c.662AG) 12 non-carriers (c.662AA). The...

10.1371/journal.pone.0176320 article EN cc-by PLoS ONE 2017-04-24

Many pharmacokinetic studies of lacosamide (LCM) have been reported, but no large-scale clinical study has conducted on genetic polymorphisms that affect the metabolism LCM. Therefore, we designed a pharmacogenetic LCM to explore effect serum concentration. We evaluated pharmacodynamic characteristics LCM, including efficacy and toxicity.Adult patients with epilepsy who received at Seoul National University Hospital were enrolled. Blood samples obtained from 115 taking for more than 1 month...

10.1111/epi.17399 article EN Epilepsia 2022-08-21

Therapeutic drug monitoring (TDM) of second-line antituberculosis drugs would allow for optimal individualized dosage adjustments and improve safety therapeutic outcomes. To evaluate the pharmacokinetic (PK) characteristics clinically relevant, multidrug treatment regimens to feasibility TDM, we conducted an open-label, multiple-dosing study with 16 healthy subjects who were divided into two groups. Cycloserine (250 mg), p-aminosalicylic acid (PAS) (5.28 g), prothionamide mg) twice daily...

10.1128/aac.00354-15 article EN Antimicrobial Agents and Chemotherapy 2015-05-19
Coming Soon ...